Effects of curcumin on ion channels and transporters

Frontiers in Physiology

Volumn 5 MAR, Issue , 2014, Pages

  Zhang, Xuemei ^a   Chen, Qijing ^a   Wang, Yunman ^b   Peng, Wen ^b   Cai, Hui ^c,d  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Curcumin; Drug targets; Ion channels; Membrane; Transporters

Indexed keywords

ABC TRANSPORTER; AQUAPORIN 4; CALCIUM CHANNEL; CARRIER PROTEIN; CHLORIDE CHANNEL; CURCUMIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FATTY ACID BINDING PROTEIN 4; FATTY ACID TRANSPORTER; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; ION CHANNEL; POTASSIUM CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1;

ANALGESIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER RESISTANCE; CONCENTRATION RESPONSE; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE MUTATION; GLUCOSE TRANSPORT; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INHIBITION KINETICS; MOLECULAR INTERACTION; MULTIDRUG RESISTANCE; NONHUMAN; POTASSIUM CURRENT; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 84897934739     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00094     Document Type: Review

References (62)

1. Anand, P., Kunnumakkara, A. B., Newman, R. A., and Aggarwal, B. B. (2007). Bioavailability of curcumin: problems and promises. Mol. Pharm. 4, 807-818. doi: 10.1021/mp700113r.
2. Anuchapreeda, S., Leechanachai, P., Smith, M. M., Ambudkar, S. V., and Limtrakul, P. N. (2002). Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol. 64, 573-582. doi: 10.1016/S0006-2952(02)01224-8.
3. Bachmeier, B. E., Iancu, C. M., Killian, P. H., Kronski, E., Mirisola, V., Angelini, G., et al. (2009). Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Mol. Cancer 8, 129. doi: 10.1186/1476-4598-8-129.
4. Bandell, M., Story, G. M., Hwang, S. W., Viswanath, V., Eid, S. R., Petrus, M. J., et al. (2004). Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41, 849-857. doi: 10.1016/S0896-6273(04)00150-3.
5. Banderali, U., Belke, D., Singh, A., Jayanthan, A., Giles, W. R., and Narendran, A. (2011). Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1. Cell. Physiol. Biochem. 28, 1169-1180. doi: 10.1159/000335850.
6. Barry, J., Fritz, M., Brender, J. R., Smith, P. E., Lee, D. K., and Ramamoorthy, A. (2009). Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J. Am. Chem. Soc. 131, 4490-4498. doi: 10.1021/ja809217u.
7. Berger, A. L., Randak, C. O., Ostedgaard, L. S., Karp, P. H., Vermeer, D. W., and Welsh, M. J. (2005). Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl-channel activity. J. Biol. Chem. 280, 5221-5226. doi: 10.1074/jbc.M412972200.
8. Bernard, K., Wang, W., Narlawar, R., Schmidt, B., and Kirk, K. L. (2009). Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms. J. Biol. Chem. 284, 30754-30765. doi: 10.1074/jbc.M109.056010.
9. Cartiera, M. S., Ferreira, E. C., Caputo, C., Egan, M. E., Caplan, M. J., and Saltzman, W. M. (2010). Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Mol. Pharm. 7, 86-93. doi: 10.1021/mp900138a.
10. Chearwae, W., Shukla, S., Limtrakul, P., and Ambudkar, S. V. (2006). Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol. Cancer Ther. 5, 1995-2006. doi: 10.1158/1535-7163.MCT-06-0087.
11. Cheng, T. C., Lin, C. S., Hsu, C. C., Chen, L. J., Cheng, K. C., and Cheng, J. T. (2009). Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats. Neurosci. Lett. 465, 238-241. doi: 10.1016/j.neulet.2009.09.012.
12. Cho, Y. A., Lee, W., and Choi, J. S. (2012). Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin. Pharmazie 67, 124-130. doi: 10.1691/ph.2012.1099.
13. Choi, S. W., Kim, K. S., Shin, D. H., Yoo, H. Y., Choe, H., Ko, T. H., et al. (2013). Class 3 inhibition of hERG K(+) channel by caffeic acid phenethyl ester (CAPE) and curcumin. Pflugers Arch. 465, 1121-1134. doi: 10.1007/s00424-013-1239-7.
14. Dash, J., and Parija, S. (2013). Spasmolytic effect of curcumin on goat ruminal artery is endothelium independent and by activation of sGC. Res. Vet. Sci. 95, 588-593. doi: 10.1016/j.rvsc.2013.04.029.
15. De Paz-Campos, M. A., Chavez-Pina, A. E., Ortiz, M. I., and Castaneda-Hernandez, G. (2012). Evidence for the Participation of ATP-sensitive potassium channels in the antinociceptive effect of Curcumin. Kor. J. Pain 25, 221-227. doi: 10.3344/kjp.2012.25.4.221.
16. Di Pierro, F., Rapacioli, G., Di Maio, E. A., Appendino, G., Franceschi, F., and Togni, S. (2013). Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva(®)), nimesulide, and acetaminophen. J. Pain Res. 6, 201-205. doi: 10.2147/JPR.S42184.
17. Dong, S. Z., Zhao, S. P., Wu, Z. H., Yang, J., Xie, X. Z., Yu, B. L., et al. (2011). Curcumin promotes cholesterol efflux from adipocytes related to PPARgamma-LXRalpha-ABCA1 passway. Mol. Cell. Biochem. 358, 281-285. doi: 10.1007/s11010-011-0978-z.
18. Dragomir, A., Björstad, J., Hjelte, L., and Roomans, G. M. (2004). Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. Biochem. Biophys. Res. Commun. 322, 447-451. doi: 10.1016/j.bbrc.2004.07.146.
19. Duncan, R. S., Goad, D. L., Grillo, M. A., Kaja, S., Payne, A. J., and Koulen, P. (2010). Control of intracellular calcium signaling as a neuroprotective strategy. Molecules 15, 1168-1195. doi: 10.3390/molecules15031168.
20. Dyer, J. L., Khan, S. Z., Bilmen, J. G., Hawtin, S. R., Wheatley, M., Javed, M. U., et al. (2002). Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 31, 45-52. doi: 10.1054/ceca.2001.0259.
21. Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glockner-Pagel, J., et al. (2004). Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304, 600-602. doi: 10.1126/science.1093941.
22. Feng, D., Ohlsson, L., and Duan, R. D. (2010). Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression. Lipids Health Dis. 9, 40. doi: 10.1186/1476-511X-9-40.
23. Foxley, S., Zamora, M., Hack, B., Alexander, R. R., Roman, B., Quigg, R. J., et al. (2013). Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus. Brain Res. 1504, 85-96. doi: 10.1016/j.brainres.2013.01.040.
24. Gao, J., Zhou, H., Lei, T., Zhou, L., Li, W., Li, X., et al. (2011). Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways. Eur. J. Pharmacol. 654, 92-99. doi: 10.1016/j.ejphar.2010.12.008.
25. Gupta, S. C., Patchva, S., and Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 15, 195-218. doi: 10.1208/s12248-012-9432-8.
26. Hong Da, H., Son, Y. K., Choi, I. W., and Park, W. S. (2013). The inhibitory effect of curcumin on voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 430, 307-312. doi: 10.1016/j.bbrc.2012.10.132.
27. Ingolfsson, H. I., Koeppe Ii, R. E., and Andersen, O. S. (2007). Curcumin is a modulator of bilayer material properties. Biochemistry 46, 10384-10391. doi: 10.1021/bi701013n.
28. Kumar, P., Malhotra, P., Ma, K., Singla, A., Hedroug, O., Saksena, S., et al. (2011). SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G148-G155. doi: 10.1152/ajpgi.00119.2011.
29. Kuo, C. P., Lu, C. H., Wen, L. L., Cherng, C. H., Wong, C. S., Borel, C. O., et al. (2011). Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage. Anesthesiology 115, 1229-1238. doi: 10.1097/ALN.0b013e31823306f0.
30. Kusuhara, H., Furuie, H., Inano, A., Sunagawa, A., Yamada, S., Wu, C., et al. (2012). Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Br. J. Pharmacol. 166, 1793-1803. doi: 10.1111/j.1476-5381.2012.01887.x.
31. Laird, M. D., Sukumari-Ramesh, S., Swift, A. E., Meiler, S. E., Vender, J. R., and Dhandapani, K. M. (2010). Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4? J. Neurochem. 113, 637-648. doi: 10.1111/j.1471-4159.2010.06630.x.
32. Leamy, A. W., Shukla, P., Mcalexander, M. A., Carr, M. J., and Ghatta, S. (2011). Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. Neurosci. Lett. 503, 157-162. doi: 10.1016/j.neulet.2011.07.054.
33. Lian, Y. T., Yang, X. F., Wang, Z. H., Yang, Y., Shu, Y. W., Cheng, L. X., et al. (2013). Curcumin serves as a human Kv1.3 blocker to inhibit effector memory T Lymphocyte activities. Phytother. Res. 27, 1321-1327. doi: 10.1002/ptr.4863.
34. Limtrakul, P., Chearwae, W., Shukla, S., Phisalphong, C., and Ambudkar, S. V. (2007). Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol. Cell. Biochem. 296, 85-95. doi: 10.1007/s11010-006-9302-8.
35. Lin, J., and Chen, A. (2011). Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2. Mol. Cell. Endocrinol. 333, 160-171. doi: 10.1016/j.mce.2010.12.028.
36. Lin, T. Y., Lu, C. W., Wang, C.-C., Wang, Y.-C., and Wang, S.-J. (2011). Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1785-1793. doi: 10.1016/j.pnpbp.2011.06.012.
37. Lipecka, J., Norez, C., Bensalem, N., Baudouin-Legros, M., Planelles, G., Becq, F., et al. (2006). Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. J. Pharmacol. Exp. Ther. 317, 500-505. doi: 10.1124/jpet.105.097667.
38. Liu, K., Gui, B., Sun, Y., Shi, N., Gu, Z., Zhang, T., et al. (2013). Inhibition of L-type Ca(2+) channels by curcumin requires a novel protein kinase-theta isoform in rat hippocampal neurons. Cell Calcium 53, 195-203. doi: 10.1016/j.ceca.2012.11.014.
39. Maheshwari, R. K., Singh, A. K., Gaddipati, J., and Srimal, R. C. (2006). Multiple biological activities of curcumin: a short review. Life Sci. 78, 2081-2087. doi: 10.1016/j.lfs.2005.12.007.
40. Mall, M., and Kunzelmann, K. (2005). Correction of the CF defect by curcumin: hypes and disappointments. Bioessays 27, 9-13. doi: 10.1002/bies.20168.
41. Martelli, L., Ragazzi, E., Di Mario, F., Martelli, M., Castagliuolo, I., Dal Maschio, M., et al. (2007). A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol. Motil. 19, 668-674. doi: 10.1111/j.1365-2982.2007.00928.x.
42. Miki, H., Zhou, Z., Li, M., Hwang, T.-C., and Bompadre, S. G. (2010). Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs. J. Biol. Chem. 285, 19967-19975. doi: 10.1074/jbc.M109.092684.
43. Orina, J. N., Calcagno, A. M., Wu, C.-P., Varma, S., Shih, J., Lin, M., et al. (2009). Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Mol. Cancer Ther. 8, 2057-2066. doi: 10.1158/1535-7163.MCT-09-0256.
44. Papadopoulos, M. C., and Verkman, A. S. (2007). Aquaporin-4 and brain edema. Pediatr. Nephrol. 22, 778-784. doi: 10.1007/s00467-006-0411-0.
45. Sakulterdkiat, T., Srisomsap, C., Udomsangpetch, R., Svasti, J., and Lirdprapamongkol, K. (2012). Curcumin resistance induced by hypoxia in HepG2 cells is mediated by multidrug-resistance-associated proteins. Anticancer Res. 32, 5337-5342.
46. Schmitz, G., Langmann, T., and Heimerl, S. (2001). Role of ABCG1 and other ABCG family members in lipid metabolism. J. Lipid Res. 42, 1513-1520.
47. Sharma, M., Manoharlal, R., Shukla, S., Puri, N., Prasad, T., Ambudkar, S. V., et al. (2009). Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals. Antimicrob. Agents Chemother. 53, 3256-3265. doi: 10.1128/AAC.01497-08.
48. Shaw, P. J., Qu, B., Hoth, M., and Feske, S. (2012). Molecular regulation of CRAC channels and their role in lymphocyte function. Cell. Mol. Life Sci. 1-20. doi: 10.1007/s00018-012-1175-2.
49. Shin, D. H., Nam, J. H., Lee, E. S., Zhang, Y., and Kim, S. J. (2012). Inhibition of Ca(2+) release-activated Ca(2+) channel (CRAC) by curcumin and caffeic acid phenethyl ester (CAPE) via electrophilic addition to a cysteine residue of Orai1. Biochem. Biophys. Res. Commun. 428, 56-61. doi: 10.1016/j.bbrc.2012.10.005.
50. Shin, D. H., Seo, E. Y., Pang, B., Nam, J. H., Kim, H. S., Kim, W. K., et al. (2011). Inhibition of Ca(2+)-release-activated Ca(2+) channel (CRAC) and K(+) channels by curcumin in Jurkat-T cells. J. Pharmacol. Sci. 115, 144-154. doi: 10.1254/jphs.10209FP.
51. Shukla, S., Zaher, H., Hartz, A., Bauer, B., Ware, J. A., and Ambudkar, S. V. (2009). Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm. Res. 26, 480-487. doi: 10.1007/s11095-008-9735-8.
52. Singer, C. (2012). Managing the patient with newly diagnosed Parkinson disease. Cleve. Clin. J. Med. 79, S3-S7. doi: 10.3949/ccjm.79.s2a.01.
53. Song, Y., Sonawane, N. D., Salinas, D., Qian, L., Pedemonte, N., Galietta, L. J., et al. (2004). Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J. Biol. Chem. 279, 40629-40633. doi: 10.1074/jbc.M407308200.
54. Sundelacruz, S., Levin, M., and Kaplan, D. L. (2009). Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev. Rep. 5, 231-246. doi: 10.1007/s12015-009-9080-2.
55. Tang, Y., and Chen, A. (2010). Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase. Br. J. Pharmacol. 161, 1137-1149. doi: 10.1111/j.1476-5381.2010.00956.x.
56. Wonderlin, W., and Strobl, J. (1996). Potassium channels, proliferation and G1 progression. J. Membr. Biol. 154, 91-107. doi: 10.1007/s002329900135.
57. Wu, C.-P., Calcagno, A. M., and Ambudkar, S. V. (2008). Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr. Mol. Pharmacol. 1, 93. doi: 10.2174/1874467210801020093.
58. Yu, L., Yi, J., Ye, G., Zheng, Y., Song, Z., Yang, Y., et al. (2012). Effects of curcumin on levels of nitric oxide synthase and AQP-4 in a rat model of hypoxia-ischemic brain damage. Brain Res. 1475, 88-95. doi: 10.1016/j.brainres.2012.07.055.
59. Yu, Y. C., Miki, H., Nakamura, Y., Hanyuda, A., Matsuzaki, Y., Abe, Y., et al. (2011). Curcumin and genistein additively potentiate G551D-CFTR. J. Cyst. Fibros. 10, 243-252. doi: 10.1016/j.jcf.2011.03.001.
60. Zhao, J. F., Ching, L. C., Huang, Y. C., Chen, C. Y., Chiang, A. N., Kou, Y. R., et al. (2012). Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Mol. Nutr. Food Res. 56, 691-701. doi: 10.1002/mnfr.201100735.
61. Zhou, H., Beevers, C. S., and Huang, S. (2011). The targets of curcumin. Curr. Drug Targets 12, 332-347. doi: 10.2174/138945011794815356.
62. Zingg, J. M., Hasan, S. T., Cowan, D., Ricciarelli, R., Azzi, A., and Meydani, M. (2012). Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages. J. Cell. Biochem. 113, 833-840. doi: 10.1002/jcb.23411.